APA (7th ed.) Citation

Y, N., T, S., J, R., T, I., D, T., H, Y., . . . S, R. (2026). Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: A propensity score-matched real-world study accounting for poor prognostic factors. Annals of the rheumatic diseases. https://doi.org/10.1016/j.ard.2026.03.029

Chicago Style (17th ed.) Citation

Y, Nozaki, et al. "Reduced Versus Standard Dosing of Janus Kinase Inhibitors in Rheumatoid Arthritis: A Propensity Score-matched Real-world Study Accounting for Poor Prognostic Factors." Annals of the Rheumatic Diseases 2026. https://doi.org/10.1016/j.ard.2026.03.029.

MLA (9th ed.) Citation

Y, Nozaki, et al. "Reduced Versus Standard Dosing of Janus Kinase Inhibitors in Rheumatoid Arthritis: A Propensity Score-matched Real-world Study Accounting for Poor Prognostic Factors." Annals of the Rheumatic Diseases, 2026, https://doi.org/10.1016/j.ard.2026.03.029.